Press Release

Best in Class: Scottsdale Wound Management Guide

Comprehensive pocket handbook offers differential diagnosis and treatment options at your fingertips

Malvern, PA (June 8, 2009) – Proper wound care management has become one of the top concerns for many clinicians across various medical specialties. Treatment is specific to the wound type, the patient and the long-term care plan and requires ongoing assessment. Read More

2009 WOUNDS Article Index

Digital Edition

Today's Wound Clinic

Interactive BONUS content delivered to your email

CLICK HERE TO CONTINUE »

CLINICAL EVENTS CALENDAR

Issue

  • Issue: 
    1 January 2010

    Abstract: Complications associated with diabetes are often expensive to treat, and commonly include foot ulceration. While most diabetic foot ulcers heal with standard treatment, when standard treatment measures fail, adjunctive therapies must be considered. We review the theory and evidence for the use of systemic Hyperbaric Oxygen Therapy (HBOT) as an adjunctive treatment for chronic lower extremity diabetic ulceration. Two clinical cases of patients treated with HBOT for refractory diabetic foot ulceration at Georgetown University Hospital are presented.

  • Issue: 
    1 January 2010

    Abstract: Purpose. Diabetes mellitus (DM) is a contributing factor to impaired wound healing in humans. A large body of evidence indicates that the diabetic state is associated with delayed or reduced wound repair capacity. The present study was designed to evaluate the efficacy of glucan on improving abdominal wall wound healing in rats with DM. Methods. Ninety-six female, Sprague-Dawley rats that weighed between 250 g and 300 g were used. A laparotomy was performed on all of the rats on the 14th day. Twenty-four healthy rats (group 1) served as the control.

  • Issue: 
    1 January 2010

    Abstract: In a randomized trial of predominantly category II and III skin tears in a population of frail elderly nursing home residents, standard wound care (24 residents) with Xeroform™ and a secondary dressing (Tegaderm™) was compared with a single application of a microbial cellulose membrane Dermafill (27 residents). Outcomes included the time to wound closure, pain reduction, and ease of use. While wound area was slightly larger in the microbial cellulose treated group, the healing time was equivalent to controls.

  • Issue: 
    1 January 2010

    Abstract: Objectives. To evaluate health-related quality of life (HRQoL) and depression in older patients with pressure ulcers who were living at home in the community. Methods. A cross-sectional analytical study conducted in southern Minas Gerais, Brazil. Forty-two outpatients 60 years and older, showing no cognitive deficit who were living in the community, participated in the study. They were divided into two groups: the study group (21 patients with pressure ulcers), and control group (21 patients without pressure ulcers).

  • Issue: 
    1 January 2010

    Dear Readers,

         A new year, a new decade—where has the time gone? It seems like just yesterday we were fretting over a potential meltdown at 12:01 am on January 1, 2000.

  • Issue: 
    1 January 2010

    Smith & Nephew Completes asset Acquisition from Nucryst Pharmaceuticals

  • Issue: 
    1 January 2010

    Derma Sciences’ Bioguard Barrier Gauze Demonstrates Efficacy Against Influenza Virus

  • Issue: 
    1 January 2010

    Abstract: Sarcoidosis, a systemic inflammatory disease of unknown cause(s), is a diagnosis of exclusion. While skin lesions are common, chronically nonhealing wounds caused by this idiopathic disease are rare and often misdiagnosed. Definitive diagnostic tests do not exist. The finding of noncaseating granulomas on biopsy of wounds is useful. Mistreatment or any delay in proper treatment of ulcerative sarcoidosis can be painful to patients. Corticosteroid therapy generally is effective.

  • Issue: 
    1 January 2010

          Utilizing his passion for the research and development of new life-saving medical technologies, mechanical engineer Ron Sechrist founded Sechrist Industries in 1973. From the beginning, Sechrist has defined its brand with a core set of values — ie, integrity, relationships, service, respect, and dedication. Today, Sechrist Industries comprises a team of distinguished professionals who work strategically to identify, develop, and sustain a worldwide competitive offering of high-quality technological solutions to the healthcare community.

  • Issue: 
    1 January 2010

         Wounds recently had the chance to talk with Kinetic Concepts, Inc.’s ([KCI] San Antonio, Texas) spokesperson Katie Gaultney to learn about her company’s efforts to provide much-needed medical supplies and aid to Haitian earthquake victims.

    WOUNDS: Mrs. Gaultney, describe KCI’s efforts on behalf of Haitian earthquake victims.





WOUNDS Monthly Poll

Ostomy Wound Management

CME Showcase

"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"

A Complimentary On-Demand CE/CME Webcast

This activity is supported by an educational grant from Advanced Biohealing.
This activity is sponsored by the North American Center For Continuing Medical Education (NACCME).

To access this Webcast, visit www.naccme.com/program/n-550/


REVIEW OUR OTHER
WOUND CARE BRANDS

Check out our other resources for healthcare professionals of all specialties.

  • Ostomy Wound Management
  • Todays Wound Clinic
  • Podiatry Today
  • Skin and Aging